Preterm Neonates Brain Ultrasound With CEUS and Elastography
Launched by TURKU UNIVERSITY HOSPITAL · Jan 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how well the brains of preterm babies are functioning as they approach their due date. Researchers want to see how blood flow and the elasticity (or stretchiness) of the brain tissue compare with results from a special type of brain scan called magnetic resonance imaging (MRI). To do this, they will use advanced ultrasound techniques that involve a contrast agent, which helps to visualize the blood flow better. The study is taking place at the Neonatal Intensive Care Unit (NICU) of Turku University Hospital and is currently looking for participants.
To be eligible for the study, babies must be preterm and scheduled for an MRI at their expected due date. However, certain conditions may exclude them from participating, such as having a known genetic condition, serious birth defects needing surgery, or issues related to their heart or lungs. Parents can expect their child to undergo both ultrasound and MRI tests, which are safe and commonly used in medical settings. This research aims to improve our understanding of brain health in preterm infants, which could lead to better care and outcomes for these vulnerable babies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm neonates attending brain MR-imaging at term
- Exclusion Criteria:
- • Pre-known genetic disease
- • Difficult congenital malformations that need surgical treatment
- • Central nervous system tumors
- • Weight less than 2,5 kg during examination
- • Medical history of SonoVue hypersensitivity
- • Uncontrolled systemic hypertension
- • Systolic pulmonary artery pressure \> 90 mmHg
- • Unstable cardiovascular state
About Turku University Hospital
Turku University Hospital (TYKS) is a leading academic medical center located in Turku, Finland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a key institution within the University of Turku, TYKS integrates cutting-edge medical education with state-of-the-art clinical services, offering a broad spectrum of specialized care. The hospital actively participates in clinical trials, facilitating the translation of scientific discoveries into practical treatments, and enhancing patient outcomes. With a multidisciplinary approach and a focus on collaboration, TYKS aims to contribute significantly to the global medical community through its rigorous research initiatives and commitment to patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Turku, Southwestern Finland, Finland
Patients applied
Trial Officials
Tiina Laurikainen
Principal Investigator
Turku University Hospital
Riitta Parkkola
Study Director
Turku University Hospital
Vilhelmiina Parikka
Study Chair
Turku University Hospital
Jussi Hirvonen
Study Chair
Turku University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials